|Price Range Ratio 52W %||47.82||Managed Assets (in ths.)||541.39K|
Today's Price Range
|Moving Averages:||Strong Sell|
The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.
|Avg. Weekly Volume||32.40K|
|Avg. Monthly Volume||20.66K|
|Avg. Quarterly Volume||17.77K|
|Dividends & Splits|
|Dividend Date||21st Dec 2020|
|Dividend Rate Ann.||0.61|
|Dividend Yield Ann.||0.33|
|Split Date||14th Feb 2012|
|Fundamentals & Details|
|Managed Assets (in ths.)||541.39K|
|First Trade Price||35.71|
|Fund Family||Van Eck ...|
|Underlying Index||MVIS US ...|
|Inception Date||21st Dec 2011|
|Equity Specialty Type||-|
|Total Holdings Count||28|
|Top 1||MRNA||Moderna Inc.||9.88%|
|Top 2||AMGN||Amgen Inc.||8.46%|
|Top 3||VRTX||Vertex Pharmaceuticals Incorporated||6.18%|
|Top 4||GILD||Gilead Sciences Inc.||5.98%|
|Top 5||IQV||IQVIA Holdings Inc.||5.80%|
|Top 6||REGN||Regeneron Pharmaceuticals Inc.||5.51%|
|Top 7||ICLR||ICON plc||5.49%|
|Top 8||BNTX||BioNTech SE||5.35%|
|Top 9||ILMN||Illumina Inc.||4.35%|
|Top 10||SGEN||Seagen Inc.||4.16%|
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.